2008 Lunch with Experts

Lunch with Experts, 12.30–1.55PM, Monday and Tuesday

Informal roundtables focusing on business, economic, political and therapeutic strategies with an international
group of stem cell leaders from corporate, academic and government sectors.

Table 1 • Us and Them: Contemplating The Psychology of the Stem Cell Research Advocate and Opponent –
Stephen E. Levick, University of Pennsylvania School of Medicine

Table 2 • ISSCR: A Global Voice for the Stem Cell Field – Nancy Witty, International Society for Stem Cell
Research

Table 3 • Venture Capital Opportunities in the Stem Cell Industry – Toucan Capital Corp. Representative

Table 4 • Effective Strategies for Your Institution’s ESCRO Committee – Carol Horvitz, ESCRO Committee
Member, Joslin Diabetes Center and Children’s Hospital Boston

Table 5 • DECELL | RECELL Technology: How 3‐D Scaffolds are Revolutionizing the Potential of Stem Cells –
Sarah Haecker, Haecker Consulting

Table 6 • How iPS Cells Highlight the Underlying Assumptions of When and How Life Begins – Lena Eriksson,
University of York

Table 7 • Stem Cells 101‐ Everything You Want to Know About Stem Cell Research But Were Afraid to Ask…..

Table 8 • Critical Allies: What Every Stem Cell Advocate Needs to Know About the Biotechnology Industry and
its Innovation Agenda – Tricia Brooks, Biotechnology Industry Organization

Table 9 • Doing Business in Stem Cells – Doug Munch, DFM, Ltd.

Table 10 • Recommendations for the Next U.S. President – Kirsten Matthews, Rice University’s James A. Baker
III Institute of Public Policy

Table 11 • International Collaboration in Stem Cell Research: Lessons From the International Stem Cell Forum
– Rosario Isasi, University of Montreal

Table 12 • Successful Business Models for Cell Based Therapies – Devyn Smith, The Frankel Group LLC

Table 13 • Building Student Support for Stem Cell Research – Joe Riggs, Student Society for Stem Cell Research

Table 14 • Hadassah’s Winning Formula for Grassroots Success – Julia Rubin, Public Policy Associate, Hadassah

Table 15 • The State of the Art on Stem Cell Therapies for Diabetes – Juan Dominguez‐ Bendala, Diabetes
Research Institute, Miami

Table 16 • International Stem Cell Policies ‐ John Hearn, University of Sydney

Table 17 • International and Regional Projects Fostering Collaborations – Maya Sieber‐Blum, Northeast
England Stem Cell Institute

Table 18 • Utilizing hESC's as Biomarkers for Disease Diagnoses and Test Agent for Toxicity – Elizabeth Donley,
Stemina Biomarker Discovery

Table 19 • Primates and Stem Cells: The Untold Story – Jordana Lenon, Wisconsin National Primate Research
Center

Table 20 • Stem Cell Research in Australia – Rebecca Skinner, Australian Stem Cell Centre

Table 21 • How Teachers and Industry Leaders Can Work Together to Boost STEM Education (Science,
Technology, Engineering and Mathematics) ‐ Jaclyn Reeves‐Pepin, National Association of Biology Teachers

Table 22 • (Monday) Harmonizing Regulation for Stem Cell Research and Medicine: Has the Time Come?
(Tuesday) Harmonizing Regulation for Stem Cell Research and Medicine: How to Proceed from Here – Alan
Jakimo, Sidley Austin LLP

Table 23 • Seeking Tr4eatment for Your Child: Parental Perspective on Ethics, Responsibility, Media and Politics
– Mary Schneider, parent of transplant patient at Duke University

Table 24 • How Maryland Leverages State Resources to Support Stem Cell Research - Dan Gincel, Maryland
Stem Cell Research Fund

Table 25 • Call to Action! The Michigan Stem Cell Initiative – Mark Burton, Michigan Citizens for Life Saving
Cures